Bristol-Myers' Opdivo racks up latest NICE rejection, this time in head and neck cancer - FiercePharma

FiercePharma

Bristol-Myers' Opdivo racks up latest NICE rejection, this time in head and neck cancer FiercePharma Bristol-Myers Squibb's Opdivo hasn't even won marketing approval for head and neck cancer in England and Wales yet, but their cost watchdog is already shutting it out. The National Institute for Health and Care Excellence on Tuesday introduced the ... NHS head and neck cancer patients barred from OpdivoPharmaTimes NHS rules out giving 'life-saving' drug to patients with head and neck cancer because it is too EXPENSIVEMirror.co.uk UK cost agency turns down Bristol drug for head and neck cancerReuters The Institute of Cancer Research -NICE -PMLiVE all 13 news articles »

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2orcAvA
via IFTTT